The 2019 Novel Wuhan Coronavirus (Covid-19) which originated from the Wuhan district of China has infected nearly 96,500 people and has claimed the lives of over 3,300 people globally. The global pandemic, as reported by the World Health Organization (WHO) has no diagnosis until today and though the survival rate is quite high, yet stringent measures need to be taken at both the micro-level and the macro-level to fight the virus. In India alone, the virus has infected 30 people, though no deaths have been reported yet. Having said that there is no diagnosis till date, precautionary measures become really important and in such a scenario adequate supply of disinfectants, masks and other medical equipment at a reasonable cost to all the people living in India become really crucial. India’s pharmaceutical industry – especially the Active Pharma Ingredients (APIs) is heavily dependent upon China.